Manufacturing

The Joint Steering Committee oversees a research pipeline that allows for the rapid pivot toward new health threats as they emerge in the Southern Hemisphere landscape. This strategic collaboration between Moderna and CSIRO establishes a robust biosecurity framework intended to fortify Australia’s

With BD products being used in ninety percent of U.S. hospital visits, the company's move to solidify domestic production is a cornerstone of national health security. For decades, the globalized medical supply chain prioritized cost efficiency over redundancy, leaving healthcare providers

A comparative study using a trastuzumab biosimilar revealed that automation can reduce the average variability in glycan profiling by twenty-eight percent compared to manual processing. This discovery comes at a critical time in 2026, as the pharmaceutical sector grapples with the increasing

BeneMeat’s partnership with the Italian brand FORZA10 serves as a practical case study for the commercial application of cultivated cells in the animal feed sector. This collaboration marks a significant milestone in the broader trajectory of cellular agriculture, moving beyond speculative research

Sustainability is increasingly viewed as a risk mitigation strategy rather than a simple cost center, directly enabling a site to double its capacity in the future. As the current landscape of late 2026 unfolds, the American biopharmaceutical manufacturing sector has transitioned from a period of

The traditional 'take-make-waste' model of medical manufacturing is being challenged by researchers who view the environmental footprint of healthcare as a critical engineering problem. For decades, the medical industry has operated under a strict mandate of patient safety and clinical sterility, a